- Company Overview for MIRZYME THERAPEUTICS LIMITED (10133310)
- Filing history for MIRZYME THERAPEUTICS LIMITED (10133310)
- People for MIRZYME THERAPEUTICS LIMITED (10133310)
- More for MIRZYME THERAPEUTICS LIMITED (10133310)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
23 Jan 2019 | AA | Total exemption full accounts made up to 30 April 2018 | |
14 Nov 2018 | AP01 | Appointment of Michael Edwin Vousden as a director on 3 October 2018 | |
10 Oct 2018 | RESOLUTIONS |
Resolutions
|
|
02 Oct 2018 | SH01 |
Statement of capital following an allotment of shares on 14 September 2018
|
|
02 Oct 2018 | SH01 |
Statement of capital following an allotment of shares on 25 July 2018
|
|
13 Sep 2018 | AP01 | Appointment of Dr Syed Omar Hayat as a director on 1 September 2018 | |
22 Apr 2018 | CS01 | Confirmation statement made on 18 April 2018 with updates | |
07 Mar 2018 | SH02 | Sub-division of shares on 30 October 2017 | |
18 Jan 2018 | AA | Accounts for a dormant company made up to 30 April 2017 | |
23 Oct 2017 | AD01 | Registered office address changed from C/O Prof Asif Ahmed Aston Medical School, Aston University, Birmingham, B4 7ET United Kingdom to Faraday Wharf, Innovation Birmingham Campus Holt Street Birmingham West Midlands B7 4BB on 23 October 2017 | |
27 Apr 2017 | CS01 | Confirmation statement made on 18 April 2017 with updates | |
19 Apr 2016 | NEWINC |
Incorporation
Statement of capital on 2016-04-19
|